Zinc sulfate compounded injection is a trace element formulation and is usually used to supplement zinc for those who have difficulties obtaining it orally or through the intestinal tract. According to the United States Pharmacopeia and the National Formulary Pharmacopeial Forum (USP 43-NF 38*), "ASSAY" for "Zinc Sulfate Compounded Injection" should be carried out with a column filled with L76 packing material. The IC YK-421, a column filled with L76 packing material, confirmed the requirements were met.
System suitability requirements Tailing factor (Standard solution): ≤ 2.0
Relative standard deviation (RSD) (Standard solution): ≤ 2.0%
*The version at the time of the application acquisition.
Sample: 10 µL
(Standard solution) Zinc sulfate 0.01 mg/mL in H2O

- Column
- :Shodex IC YK-421 (4.6 mm I.D. x 125 mm)
- Eluent
- :3 mM Nitric acid aq.
- Flow rate
- :0.9 mL/min
- Detector
- :Non-suppressed conductivity
- Column temp.
- :40 ℃
Sample Name Index
Operation Manual / Certificate of Analysis
Operation Manuals and Certificate of Analysis / Inspection Certificate for the following products can be downloaded here.
Product Name Index
Applications
- Analysis of Erythropoietin According to EP Method (LW-803)
- Analysis of Somatropin According to EP Method (LW-803)
- Analysis of Teriparatide According to EP Method (KW-802.5)
- Analysis of myo-Inositol According to EP Method (SC1011-7F)
- Analysis of Ethylcellulose Dispersion Type B According to USP-NF Method (KF-802)
- Analysis of Azithromycin According to USP-NF Method (ODP-50 4E)
- Analysis of Azithromycin for Injection According to USP-NF Method (ODP-50 4D)
- Analysis of Ascorbic Acid Injection According to USP-NF Method (DM-614)
- Analysis Alanine and Aspartic Acid According to USP-NF Method (SH1011)
- Analysis of Insulin According to USP-NF GENERAL CHAPTERS "<121.1> PHYSICOCHEMICAL ANALYTICAL PROCEDURES FOR INSULINS" (KW-802.5)
- Analysis of Exenatide Injection According to USP-NF Method (KW-802.5)
- Analysis of Epoetin According to USP-NF Method (LW-803)
- Analysis of Omega-3 Free Fatty Acids According to USP-NF Method (KF-802.5 + KF-802 + KF-801)
- Analysis of Xylitol According to USP-NF Method (SP0810)
- Analysis of Guar Gum According to USP-NF Method (SP0810)
- Analysis of Cranberry Fruit Juice According to USP-NF Method (SC1011-7F)
- Analysis of Zanamivir According to USP-NF Method (NH2P-50 4E)
- Analysis of Cefepime for Injection According to USP-NF Method (YK-421)
- Analysis of Sorbitol According to USP-NF Method (SP0810 8C)
- Analysis of Tagatose According to USP-NF Method (SC1011)
- Analysis of Dextrose According to USP-NF Method (SC1011)
- Analysis of Trehalose According to USP-NF Method (KS-801)
- Analysis of Pamidronate Disodium According to USP-NF Method (IC I-524A)
- Analysis of Betadex Sulfobutyl Ether Sodium According to USP-NF Method (SB-803 HQ)
- Analysis of Polyethylene Glycol 3350 According to USP-NF Method (2) (SB-803 HQ)
- Analysis of Polyethylene Glycol 3350 According to USP-NF Method (SB-802.5 HQ)
- Analysis of Polyethylene Glycol 3350 for Oral Solution According to USP-NF Method (SB-802.5 HQ)
- Analysis of Voriconazole According to USP-NF Method (CDBS-453)
- Analysis of Maltitol and Maltitol Solution According to USP-NF Method (SP0810 8C)
- Analysis of Maltose According to USP-NF Method (KS-801)
- Analysis of Propylene Glycol Monocaprylate According to USP-NF Method (KF-801)
- Analysis of Lamivudine According to USP-NF Method (CDBS-453)
- Analysis of Ribose According to USP-NF Method (KS-801)
- Analysis of Calcium Acetate Capsules According to USP-NF Method (YK-421)
- Analysis of Ibandronate Sodium According to USP-NF Method (I-524A)
- Analysis of Fluorouracil Injection According to USP-NF Method (SB-802.5 HQ)
- Analysis of Mannitol Compounded Injection According to USP-NF Method (SP0810)
- Analysis of Potassium Bicarbonate and Potassium Chloride Effervescent Tablets for Oral Solution According to USP-NF Method (YK-421)
- Analysis of Potassium and Sodium Bicarbonates and Citric Acid Effervescent Tablets for Oral Solution According to USP-NF Method (YK-421)
- Analysis of Glyceryl Stearate According to USP-NF Method (KF-802)
- Analysis of Glyceryl Distearate According to USP-NF Method (KF-802)
- Analysis of Glyceryl Tristearate According to USP-NF Method (KF-802)
- Analysis of Glyceryl Monooleate According to USP-NF Method (KF-802)
- Analysis of Glyceryl Monolinoleate According to USP-NF Method (KF-802)
- Analysis of Low Molecular Weight Heparin According to USP-NF GENERAL CHAPTERS ”<209> Low Molecular Weight Heparin Molecular Weight Determinations" (KW-803 + KW-802.5)
- Analysis of PMMA According to USP-NF GENERAL CHAPTERS ”<314> Molecular Weight Determination for Copolymers Containing Alkyl Methacrylate or Alkyl Acrylate" (LF-804)
- Analysis of Erythritol in According to USP-NF Method (SH1011)
- Analysis of Malic Acid According to USP-NF Method (SH1011)
- Analysis of Polydextrose According to USP-NF Method (SH1011)
- Analysis of Polydextrose According to USP-NF Method (2) (SB-804 HQ)
- Analysis of Hydrogenated Polydextrose According to USP-NF Method (SH1011)
- Analysis of Hydrogenated Polydextrose According to USP-NF Method (2) (SB-804 HQ)
- Analysis of Azithromycin Hydrate According to JP Method (ODP-50 4E)
- Analysis of Alendronate Sodium Hydrate According to JP Method (DS-413)
- Analysis of Alendronate Sodium Hydrate According to JP Method (2) (DS-413)
- Analysis of Alendronate Sodium Tablets According to JP Method (DS-613)
- Analysis of Alendronate Sodium Injection According to JP Method (DS-613)
- Analysis of Insulin Glargine (Genetical Recombination) and Insulin Glargine (Genetical Recombination) Injection According to JP Method (KW-802.5)
- Analysis of Trehalose According to JP Method (KS-801)
- Analysis of Insulin Human (Genetical Recombination) and Insulin Human (Genetical Recombination) Injection According to JP Method (KW-802.5)
- Analysis of Voglibose According to JP Method (NH2P-50 4E)
- Analysis of Maltose Hydrate According to JP Method (KS-801)
- Analysis of Miglitol According to JP Method (NH2P-50 4E)
- Analysis of Lactulose According to JP Method (SP0810)
- Analysis of Purified Sodium Hyaluronate Ophthalmic Solution According to JP Method (SB-802.5 HQ)
- Analysis of Insulin Aspart According to Pharmacopeia Method (KW-802.5)
- Analysis of Povidone According to Pharmacopeia Method (KC-811)
- Analysis of Mannitol According to Pharmacopeia Method (SC1011-7F)
